DIN 02418282 — ULTIBRO BREEZHALER 50 MCG; 110 MCG
ULTIBRO BREEZHALER is a capsule of Indacaterol / Glycopyrronium marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Indacaterol / Glycopyrronium monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02418282
- Brand name
- ULTIBRO BREEZHALER
- Active ingredient
- Indacaterol / Glycopyrronium
- Strength
- 50 MCG; 110 MCG
- Dosage form
- CAPSULE
- Route
- INHALATION
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Long-acting beta2-adrenergic agonist (LABA) and long-acting muscarinic antagonist (LAMA) combination bronchodilator
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.